Sacomed ApS   Report issue

For profit
Founded: Brøndbyvester Denmark (2009)
Status: Left NME R&D (2014)

Organization Overview

First Clinical Trial
2014
NCT02158013
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

carboxymethyl glucan (1 trial)

diltiazem (cardizem) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2